-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharma Network September 25th, September 23rd, Shanghai Free Trade Zone Bonded Zone, two foreign-funded enterprises - Xeronic Medical Products International Trade (Shanghai) Co., Ltd. and WeiChengli (Shanghai) Metal Parts Co., Ltd. signed a contract on September 22nd, will cooperate in the production of ultra-high definition endoscope camera system.
"marriage" between two foreign companies in China will boost the local production of this high-end medical device.
this "marriage" comes from the efforts and institutional innovation of the Shanghai Free Trade Zone Bonded Zone Authority.
, medical device product registration and production are tightly tied together, medical device enterprises in China to open up the market needs to build their own production lines.
Aminde, managing director of Xerk hui in Greater China, said it would take three to five years for the company to register itself for production under the previous registration process.
can we realize the local production of this medical device as soon as possible? According to the Shanghai 2017 "China (Shanghai) Free Trade Pilot Zone Medical Device Registrar System Implementation Program": "Registered persons who do not have the corresponding production qualifications and capabilities may directly entrust Shanghai medical device manufacturers to produce products."
", this achieves the medical device product registration and production license "untied", for the new product to speed up the landing of the conditions.
the beginning of this year, the Shanghai Free Trade Zone Bonded Zone Administration in the enterprise visit, learned about the transformation and upgrading of The great power and Xerrer Hui research and development production localization needs.
through precise matchmaking and matchmaking, the two sides finally reached this cooperation.
", the time it takes Chinese patients to use the new product has been reduced from three to five years to one and a half years.
" Amminde said Xerus also plans to have about 100 new products into the Chinese market in the future, many of which can be used in the medical device registrar system to speed up the pace of landing.
more than three years since the implementation of
, more than 100 products of 19 enterprises in Shanghai have been approved through the medical device registrar system, creating conditions for the groupization, specialization and international development of the medical device industry.
," said Guo Shiting, deputy director of the Shanghai Municipal Drug Administration.
Chen Yanfeng, deputy director of the Shanghai Free Trade Area Management Committee, said that Xerenoic and Wei Chengli two foreign enterprises in China reached cooperation, is the enterprise with the help of institutional innovation, work together to open up the Chinese market a new starting point, will also accelerate the Shanghai Free Trade Zone bonded area medical device industry gathering, promote regional dynamic energy conversion and industrial upgrading.
Despite the impact of the outbreak, but benefiting from institutional innovation, functional innovation and service innovation demonstration-driven effect, the Shanghai Free Trade Zone Free Trade Zone free trade zone's main economic indicators did not decline and increase: from January to August this year, the bonded zone completed a total of 692.2 billion yuan in imports and exports, an increase of 1.7% year-on-year.
.